Texas SB 2212: Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.

Status: Referred to Public Health (as of 2023-05-06)

State: Texas · Session: 88 · Bill: SB 2212

Subjects: Insurance--Health & Accident (I0422), MEDICINE & PRESCRIPTION DRUGS (S7338), Occupational Regulation--Health Occupations (I0540), PHARMACIES & PHARMACISTS (S1192)

Sponsors: Blanco

View Texas SB 2212 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.